Longitudinal follow‐up and performance validation of an mRNA‐based urine test (Xpert(®) Bladder Cancer Monitor ) for surveillance in patients with non‐muscle‐invasive bladder cancer

OBJECTIVE: To evaluate the performance of the Xpert Bladder Cancer Monitor (Xpert; Cepheid, Sunnyvale, CA, USA) test as a predictor of tumour recurrence in patients with non‐muscle‐invasive bladder cancer (NMIBC). PATIENTS AND METHODS: Patients (n = 429) undergoing surveillance for NMIBC underwent X...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, Barrett, Klein, Eric, Jansz, Ken, Westenfelder, Karl, Bradford, Timothy, Peterson, Chad, Scherr, Douglas, Karsh, Lawrence I., Egerdie, Blair, Witjes, Alfred, Trainer, Andrew, Harris, Richard, Goldfarb, Bernard, Flax, Stanley, Kroeger, Robert, Boyd, Buffi, Liao, Joseph, Patel, Sanjay, Bridge, Julia, Reuter, Victor, Quigley, Neil, Brown, Sarah, Zhao, Suling, Satya, Malini, Bates, Michael, Simon, Iris M., Campbell, Scott, Lotan, Yair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292663/
https://www.ncbi.nlm.nih.gov/pubmed/33793062
http://dx.doi.org/10.1111/bju.15418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292663/
https://www.ncbi.nlm.nih.gov/pubmed/33793062
http://dx.doi.org/10.1111/bju.15418

Ejemplares similares